Related references
Note: Only part of the references are listed.Continuous Viral Escape and Selection by Autologous Neutralizing Antibodies in Drug-Naive Human Immunodeficiency Virus Controllers
Madhumita Mahalanabis et al.
JOURNAL OF VIROLOGY (2009)
Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants
M. -R. Abrahams et al.
JOURNAL OF VIROLOGY (2009)
Importance of the V1/V2 Loop Region of Simian-Human Immunodeficiency Virus Envelope Glycoprotein gp120 in Determining the Strain Specificity of the Neutralizing Antibody Response
Melissa E. Laird et al.
JOURNAL OF VIROLOGY (2008)
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
Evelien M. Bunnik et al.
JOURNAL OF VIROLOGY (2008)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF VIROLOGY (2008)
Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study
Francois van Loggerenberg et al.
PLOS ONE (2008)
Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
Penny L. Moore et al.
JOURNAL OF VIROLOGY (2008)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Unique mutational patterns in the envelope α2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1
Rong Rong et al.
JOURNAL OF VIROLOGY (2007)
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
E. S. Gray et al.
JOURNAL OF VIROLOGY (2007)
Clade-specific differences between human immunodeficiency virus type 1 clades B and C: Diversity and correlations in C3-V4 regions of gp120
S. Gnanakaran et al.
JOURNAL OF VIROLOGY (2007)
Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to neutralization during clade C infection
Rong Rong et al.
JOURNAL OF VIROLOGY (2007)
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
Manish Sagar et al.
JOURNAL OF VIROLOGY (2006)
Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1
C. P. Krachmarov et al.
JOURNAL OF VIROLOGY (2006)
Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B
Elin Solomonovna Gray et al.
PLOS MEDICINE (2006)
Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope
Lan Wu et al.
VACCINE (2006)
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1
Bing Li et al.
JOURNAL OF VIROLOGY (2006)
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
Y Li et al.
JOURNAL OF VIROLOGY (2006)
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
SDW Frost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure of a V3-containing HIV-1 gp120 core
CC Huang et al.
SCIENCE (2005)
N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies
S Teeraputon et al.
VIRAL IMMUNOLOGY (2005)
The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates
A Pinter et al.
JOURNAL OF VIROLOGY (2005)
Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B V3 domains are common in patient sera from cameroon, but their neutralization activity is usually restricted by epitope masking
C Krachmarov et al.
JOURNAL OF VIROLOGY (2005)
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission
CA Derdeyn et al.
SCIENCE (2004)
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins:: HIV, SIV, and HCV envelopes and influenza hemagglutinin
M Zhang et al.
GLYCOBIOLOGY (2004)
The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection
A Pinter et al.
JOURNAL OF VIROLOGY (2004)
A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1
R Geffin et al.
VIROLOGY (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual
DC Montefiori et al.
JOURNAL OF IMMUNOLOGY (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
AIDS - Diversity considerations in HIV-1 vaccine selection
B Gaschen et al.
SCIENCE (2002)
Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
XG Zhu et al.
BIOCHEMISTRY (2000)
Share Paper
